SCHEDULE 13G/A: Revelation Healthcare Fund I Divests Entire Stake in CalciMedica, Inc.

Sentiment:

Schedule 13G Amendment 14 February 2025 3:56 PM

Revelation Healthcare Fund I and its affiliated entities have reported a complete divestment of their beneficial ownership in CalciMedica, Inc., holding 0.0% of the common stock as of December 31, 2024.

Worse than expectedThe complete divestment of shares by Revelation Healthcare Fund I indicates a loss of confidence or a strategic exit by a significant investor, which is generally perceived negatively by the market and could put downward pressure on CalciMedica, Inc.'s stock price.

Summary

Revelation Healthcare Fund I, L.P., Revelation Healthcare Fund I GP, L.P., Revelation Healthcare Fund I GP, LLC, Scott Halsted, and Michael Boggs are the reporting persons.
The filing is an Amendment No. 1 to Schedule 13G, indicating a change from a previous filing.
As of December 31, 2024, the reporting persons beneficially own 0.00 shares of CalciMedica, Inc. Common Stock, representing 0.0% of the class.
The principal business office of the reporting persons is 300 Turney Street, Sausalito, CA 94965.
CalciMedica, Inc.'s principal executive offices are located at 505 Coast Boulevard South, Suite 307, La Jolla, CA 92037.

Sentiment

Score: 3

Explanation: The complete divestment by an institutional investor is a negative signal, indicating a lack of confidence or a strategic exit from the company's stock.

Negatives

A significant institutional investor, Revelation Healthcare Fund I, has completely divested its stake in CalciMedica, Inc., which may signal a lack of confidence in the company's future prospects from this investor's perspective.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding CalciMedica, Inc.'s future performance or strategic direction.

Industry Context

This filing is a standard disclosure of a change in beneficial ownership by an institutional investor. It does not provide broader industry trends or competitive analysis, but the complete divestment by a healthcare-focused fund could be interpreted within the context of the biotech or pharmaceutical sector's investment climate.

Stakeholder Impact

Shareholders: May experience negative sentiment and potential downward pressure on stock price due to the complete divestment by an institutional investor, signaling a lack of confidence.

Key Dates

Date	Description
12/31/2024	Date of event which requires filing of this statement (beneficial ownership change).
02/14/2025	Date the Schedule 13G/A filing was signed by the reporting persons.

Recommendation

sell

Keywords

CalciMedica Inc., Revelation Healthcare Fund I, SEC Filing, Schedule 13G, Beneficial Ownership, Stock Divestment, Institutional Investor, Common Stock, Healthcare Investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.